Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation …

…, A Hazout, R Mendoza-Tesarik, N Mendoza… - Human …, 2006 - academic.oup.com
BACKGROUND: GnRH agonist was recently suggested as a novel luteal-phase support that
may act at different levels, including the pituitary gonadotrophs, the endometrium and the …

Relationship of body mass index and body fat distribution with postural balance and risk of falls in Spanish postmenopausal women

…, R Lomas-Vega, P Álvarez, N Mendoza… - Menopause, 2013 - journals.lww.com
Objective Menopause status has been associated with weight gain and increased central
adiposity. Obesity and postural instability are related to an increased risk of falls. The purpose …

Androgen insensitivity syndrome

N Mendoza, MA Motos - Gynecological Endocrinology, 2013 - Taylor & Francis
Androgen insensitivity syndrome (AIS) is a disorder caused by a mutation of the gene encoding
the androgen receptor (AR; Xq11–q12). The prevalence of AIS has been estimated to be …

Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study

…, JV González, R Lertxundi, MT Martínez, N Mendoza… - Contraception, 2007 - Elsevier
BACKGROUND: Contraceptive efficacy and side effects are primary concerns of women when
choosing a contraceptive method. STUDY DESIGN: This cross-sectional multicenter study …

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical …

N Mendoza, I Ramírez, E De la Viuda, P Coronado… - Maturitas, 2022 - Elsevier
This project aims to develop eligibility criteria for menopausal hormone therapy (MHT). The
tool should be similar to those already established for contraception A consortium of scientific …

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

…, C Hartley, AL Hirschberg, B Meczekalski, N Mendoza… - Maturitas, 2022 - Elsevier
This care pathway from the European Menopause and Andropause Society (EMAS) provides
an updated pathway for monitoring and guidance of women at midlife, focusing on those …

Benefits of physical exercise in postmenopausal women

N Mendoza, C De Teresa, A Cano, D Godoy… - Maturitas, 2016 - Elsevier
Physical inactivity not only places women's health at risk during menopause, but also
increases menopausal problems. Abundant evidence links habitual physical exercise (PE) to a …

The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement

…, A Kydd, S Marshall, B Meczekalski, N Mendoza… - Maturitas, 2022 - Elsevier
… Kydd q , Skye Marshall r s , Blazej Meczekalski t , Nicolas Mendoza u … Irene Lambrinoudaki
ff … Nicolas Mendoza in the past 3 years has received grant support from Astellas Pharma. …

Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program: a randomized controlled trial

…, R Mendoza-Tesarik, C Mendoza… - Journal of the …, 2018 - academic.oup.com
Background and Objective Administration of growth hormone (GH) during ovarian stimulation
has been shown to improve success rates of in vitro fertilization. GH beneficial effect on …

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish …

…, L Baquedano, P Coronado, P Llaneza, N Mendoza… - Maturitas, 2020 - Elsevier
… Coronado a b , Plácido Llaneza a b , Nicolás Mendoza a b , Borja Otero a b , Sonia Sánchez
a b , … Nicolás Mendoza contributed to conception and design of the idea, and preparation of …